Trials / Completed
CompletedNCT04272502
Clinical Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-348 in Healthy Volunteers
Phase I Clinical Trial to Compare the Pharmacokinetics and Safety of CKD-348 in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- Male
- Age
- 19 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
Phase I clinical trial to compare the pharmacokinetics and safety of CKD-348 with co-administration of CKD-828, D326 and D337 in healthy adult volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CKD-348 F1, CKD-348 F2, CKD-828, D326, D337 | Each arm has a different order for taking IP |
Timeline
- Start date
- 2019-06-04
- Primary completion
- 2019-08-26
- Completion
- 2019-08-26
- First posted
- 2020-02-17
- Last updated
- 2020-02-17
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT04272502. Inclusion in this directory is not an endorsement.